Two different single-dose allergen-blocking antibodies, one for cat allergy and one for birch allergy, significantly reduced allergic ocular symptoms, according to findings from two phase 3 trials.

“I just have to think that Kansas can do better than this,” said Teresa Woody, litigation director of Kansas Appleseed, one of four entities that filed the class ...